Home
>
siRNA Synthesis Service
>
RNAi Information
>
News
RNAi: Nobel Prize-Winning Biotechnology
(2006-11-01)
Merck's risky bet on a little biotech
(2006-11-01)
Alnylam achieves RNAi breakthrough
(2006-04-08)
GSK and Sirna in $700 million alliance
(2006-04-08)
RNA: Rule Breaker Nucleic Acid
(2006-02-11)
Team Uses RNAi to Target Diabetes, Obesity
(2006-02-11)
RNAi was identified as one of "areas to watch in 2006" by Science journal.
(2005-12-27)
Sirna Therapeutics Selects Development Candidate for Its Hepatitis C Antiviral Program
(2005-12-27)
Alnylam files for human clinical trial
(2005-11-03)
New RNAi Approach for In Vivo Therapeutic
(2005-11-03)
Title
Contents
Source
Page1
2